New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Dyadic International Inc. (DYAI) vs Passage Bio, Inc. (PASG)
- Dyadic International Inc. DYAI 0.29 −6.45%
- Passage Bio, Inc. PASG 3.92 +8.59%
Dyadic International Inc. and Passage Bio, Inc. are both Biotechnology companies. Dyadic International Inc. and Passage Bio, Inc. are of similar size ($12.5M and $11.6M). Across the 8 metrics below, Dyadic International Inc. leads on 5 and Passage Bio, Inc. on 3.
Valuation
Profitability
| Metric | DYAI | PASG | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | — | 70.18% |
| Operating margin | (237.12%) | — | 0.00% |
| Net margin | (226.87%) | — | 0.00% |
| Free cash flow margin | (227.93%) | — | 0.00% |
| Return on equity | (47,316.89%) | (212.27%) | (51.58%) |
| Return on assets | (71.43%) | (69.68%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack